June 15, 2023
By David Statman
In this video, Andrew Tiu, MD, discussed results from a study regarding the link between Agent Orange and myeloproliferative neoplasms, which he presented at ASCO Annual Meeting.
Tiu, a hematology/oncology fellow at MedStar Georgetown University Hospital, noted that the study showed an increased likelihood for developing myeloproliferative neoplasms after exposure to Agent Orange, as well as several other conditions.
“We look forward to looking more into the cardiovascular outcomes with myeloproliferative neoplasms, as well as Agent Orange exposure,” Tiu said.
Read more